Lancet Neurol (2020) 19:1112
Aberrations in carnitine regulation are implicated in complications of diabetes mellitus, hemodialysis, trauma, malnutrition, cardiomyopathy, obesity, fasting, drug interactions, endocrine imbalances and other disorders
The FDA-approved Wegovy and Zepbound titration schedules are starting points, not requirements
Clinical trials showed average weight loss of 22.5% of total body weight over approximately 72 weeks
The drug also improved several cardiovascular risk markers, including waist size, cholesterol levels, triglycerides, blood pressure and inflammation levels